Michel Burnier

ORCID: 0000-0003-1283-8487
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Sodium Intake and Health
  • Hormonal Regulation and Hypertension
  • Medication Adherence and Compliance
  • Renin-Angiotensin System Studies
  • Nutritional Studies and Diet
  • Electrolyte and hormonal disorders
  • Heart Rate Variability and Autonomic Control
  • Dialysis and Renal Disease Management
  • Renal and Vascular Pathologies
  • Renal function and acid-base balance
  • Cardiovascular Health and Disease Prevention
  • Chronic Kidney Disease and Diabetes
  • Pharmaceutical Practices and Patient Outcomes
  • Heart Failure Treatment and Management
  • Health, Medicine and Society
  • Healthcare Systems and Practices
  • Ion Transport and Channel Regulation
  • Birth, Development, and Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Parathyroid Disorders and Treatments
  • Hemodynamic Monitoring and Therapy
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pharmaceutical Economics and Policy
  • Diabetes Treatment and Management

University of Lausanne
2016-2025

University Hospital of Lausanne
2015-2024

Gdańsk Medical University
2022-2024

University of Milano-Bicocca
2017-2024

American Medical Association
2024

Oslo University Hospital
2024

University of Oslo
2024

Universidad de Granada
2023

ChemoCentryx (United States)
2023

Hôpital Orthopédique de la Suisse Romande
2006-2022

Bryan Williams Giuseppe Mancia Wilko Spiering Enrico Agabiti Rosei Michel Azizi and 95 more Michel Burnier Denis L Clement António Coca Giovanni de Simone Anna F. Dominiczak Thomas Kahan Felix Mahfoud Josep Redón Luís M. Ruilope Alberto Zanchetti Mary Kerins Sverre E. Kjeldsen Reinhold Kreutz Stéphane Laurent Gregory Y H Lip Richard J. McManus Krzysztof Narkiewicz Frank Ruschitzka Roland E. Schmieder Е. V. Shlyakhto Costas Tsioufis Victor Aboyans Iléana Desormais Guy De Backer Anthony M. Heagerty Stefan Agewall Murielle Bochud Claudio Borghi Pierre Boutouyrie Jana Brguljan Héctor Bueno Enrico G. Caiani Bo Carlberg Neil Chapman Renata Cífková John G.F. Cleland Jean-Philippe Collet Ioan Mircea Coman Peter W. de Leeuw Victoria Delgado Paul Dendale Hans‐Christoph Diener Maria Dorobanţu Robert Fagard Csaba Farsang Marc Ferrini Ian M Graham Guıdo Grassı Hermann Haller F D Richard Hobbs Bojan Jelakovic Catriona Jennings Hugo A Katus Abraham A Kroon Christophe Leclercq Dragan Lovic Empar Lurbe Athanasios Manolis Theresa A McDonagh Franz H. Messerli Maria Lorenza Muiesan Uwe Nixdorff Michael Hecht Olsen Gianfranco Parati Joep Perk Massimo Piepoli Jorge Polonia Piotr Ponikowski Dimitrios J Richter Stefano F. Rimoldi Marco Roffi Naveed Sattar Petar Seferovic Iain A Simpson Georges Saadé Alice Stanton Philippe van de Borne Panos E. Vardas Massimo Volpe Sven Waßmann Stephan Windecker Jose Luis Zamorano Stephan Windecker Victor Aboyans Stefan Agewall Emanuele Barbato Héctor Bueno Antonio Coca Jean-Philippe Collet Ioan Mircea Coman Verónica Dean Victoria Delgado Donna Fitzsimons O. Gaemperli Gerhard Hindricks

The ESC/ESH Guidelines represent the views of ESC and ESH were produced after careful consideration scientific medical knowledge evidence available at time their dating.The are not responsible in event any contradiction, discrepancy, and/or ambiguity between other official

10.1093/eurheartj/ehy339 article EN European Heart Journal 2018-08-25

Document reviewers: Guy De Backer (ESC Review Co-ordinator) (Belgium), Anthony M. Heagerty (ESH (UK), Stefan Agewall (Norway), Murielle Bochud (Switzerland), Claudio Borghi (Italy), Pierre Boutouyrie (France), Jana Brguljan (Slovenia), Héctor Bueno (Spain), Enrico G. Caiani Bo Carlberg (Sweden), Neil Chapman Renata Cifkova (Czech Republic), John F. Cleland Jean-Philippe Collet Ioan Mircea Coman (Romania), Peter W. de Leeuw (The Netherlands), Victoria Delgado Paul Dendale Hans-Christoph...

10.1097/hjh.0000000000001940 article EN Journal of Hypertension 2018-10-01

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici (Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luís Bronze (Portugal), John Chalmers (Australia), Tine De Backer (Belgium), Alejandro de la Sierra (Spain), Kyriakos Dimitriadis Dorota Drozdz (Poland), Béatrice Duly-Bouhanick (France), Brent M. Egan (USA), Serap Erdine Claudio Ferri (Italy), Slavomira Filipova (Slovak Republic), Anthony Heagerty (UK), Michael Hecht Olsen (Denmark), Dagmara Hering...

10.1097/hjh.0000000000003480 article EN Journal of Hypertension 2023-06-24

Abbreviations ACE: angiotensin-converting enzyme; BP: blood pressure; DBP: diastolic eGFR: estimated glomerular filtration rate; ESC: European Society of Cardiology; ESH: Hypertension; ET: endothelin; IMT: carotid intima-media thickness; JNC: Joint National Committee; LVH: left ventricular hypertrophy; LVM: mass; PDE-5: phosphodiesterase-5; PPAR-γ: peroxisome proliferators-activated receptor-γ; PWV: pulse wave velocity; SBP: systolic WHO: World Health Organization. Introduction In the 2...

10.1097/hjh.0b013e328333146d article EN Journal of Hypertension 2009-10-21

<b>Objective</b> To describe characteristics of dosing history in patients prescribed a once day antihypertensive medication. <b>Design</b> Longitudinal database study. <b>Setting</b> Clinical studies archived for 1989-2006. <b>Participants</b> Patients who participated the whose histories were available through electronic monitoring. <b>Main outcome measures</b> Persistence with treatment and execution their drug regimens. <b>Results</b> The contained 4783 hypertension. data came from 21...

10.1136/bmj.39553.670231.25 article EN BMJ 2008-05-14

Hypertension is a heritable and major contributor to the global burden of disease. The sum rare common genetic variants robustly identified so far explain only 1%–2% population variation in BP hypertension. This suggests existence more undiscovered variants. We conducted genome-wide association study 1,621 hypertensive cases 1,699 controls follow-up validation analyses 19,845 16,541 using an extreme case-control design. locus on chromosome 16 5′ region Uromodulin (UMOD; rs13333226, combined...

10.1371/journal.pgen.1001177 article EN cc-by PLoS Genetics 2010-10-28

The prevalence of hyperuricemia has rarely been investigated in developing countries. purpose the present study was to investigate and association between uric acid levels various cardiovascular risk factors a country with high average blood pressures (the Seychelles, Indian Ocean, population mainly African origin). This cross-sectional health examination survey based on random sample from Seychelles. It included 1011 subjects aged 25 64 years. Blood pressure (BP), body mass index (BMI),...

10.1186/1471-2458-4-9 article EN cc-by BMC Public Health 2004-03-25

Abstract Systemic arterial hypertension (referred to as herein) is a major risk factor of mortality worldwide, and its importance further emphasized in the context novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection referred COVID-19. Patients with COVID-19 infections commonly are older have history hypertension. Almost 75% patients who died pandemic Italy had This raised multiple questions regarding more course relation itself well treatment renin–angiotensin system...

10.1093/cvr/cvaa097 article EN other-oa Cardiovascular Research 2020-04-06

Renal tissue hypoxia is a final pathway in the development and progression of chronic kidney disease (CKD), but whether renal oxygenation predicts function decline humans has not been proven. Therefore, we performed prospective study measured by blood level-dependent magnetic resonance imaging (BOLD-MRI) 112 patients with CKD, 47 hypertension without 24 healthy control individuals. Images were analyzed twelve-layer concentric objects method that divided parenchyma 12 layers equal thickness...

10.1016/j.kint.2017.10.020 article EN cc-by-nc-nd Kidney International 2018-01-09

The present paper provides an update of previous recommendations on Home Blood Pressure Monitoring from the European Society Hypertension (ESH) Working Group and Cardiovascular Variability sequentially published in years 2000, 2008 2010. This has taken into account new evidence this field, including a recent statement by American Heart association, as well technological developments, which have occurred over past 20 years. document been developed same ESH with inputs international team...

10.1097/hjh.0000000000002922 article EN Journal of Hypertension 2021-07-16
Coming Soon ...